eMedicine Specialties > Dermatology > Diseases of the Vessels
Actinic Purpura: Follow-up
Updated: May 12, 2008
Follow-up
Inpatient & Outpatient Medications
- Recommend the use of sunscreens that provide both UV-A and UV-B protection.
Deterrence/Prevention
- Actinic purpura can be prevented by using lifelong sun protection.
- Advise patients to adhere to the following precautions, starting at the earliest possible age.
- Avoid sun exposure when the most damaging rays are present (ie, from 10 am to 3 pm).
- Wear clothing at all times while outdoors to serve as barrier protection from the sun's UV rays.
- Apply sunscreens that protect against UV-A and UV-B radiation daily, especially to areas of the skin that are not covered by barrier protection.
Complications
- Actinic purpura is a benign condition and does not have serious complications.
- The lesions may be emotionally distressing to patients because of the cosmetic disfigurement of the skin.
Prognosis
- Individual lesions of actinic purpura generally resolve within 1-3 weeks.
- Residual hemosiderosis may occur. Purpuric lesions usually continue to occur during the individual's life.
Patient Education
- Reassure the patient that this condition is benign.
- Emphasize the absolute necessity of using sunscreen and barrier protection to prevent further photodamage.
- Inform patients that sunscreens do not reverse photodamage.
- Instruct patients to minimize any trauma to the skin where the purpuric lesions are present.
Miscellaneous
Medicolegal Pitfalls
- The clinical sign of purpura is not necessarily benign.
- Although actinic purpura does not have serious sequelae, other causes of purpura can be serious.
- An incorrect diagnosis as to the etiology of purpuric lesions can be medically and legally disastrous.
More on Actinic Purpura |
| Overview: Actinic Purpura |
| Differential Diagnoses & Workup: Actinic Purpura |
| Treatment & Medication: Actinic Purpura |
Follow-up: Actinic Purpura |
| References |
| « Previous Page |
References
Bateman T. Exanthemata. In: A Practical Synopsis of Cutaneous Diseases. London, England: Longman, Hurst, Reese and Brown; 1818:118-9.
Kaya G, Saurat JH. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology. 2007;215(4):284-94. [Medline].
Shuster S. Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med Hypotheses. 2005;65(3):426-32. [Medline].
Carlson JA, Chen KR. Cutaneous pseudovasculitis. Am J Dermatopathol. Feb 2007;29(1):44-55. [Medline].
Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. Dec 1987;123(12):1638-43. [Medline].
Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed. Dec 2000;16(6):239-44. [Medline].
Bockholdt B, Maxeiner H, Hegenbarth W. Factors and circumstances influencing the development of hemorrhages in livor mortis. Forensic Sci Int. May 10 2005;149(2-3):133-7. [Medline].
Chong BH, Ho SJ. Autoimmune thrombocytopenia. J Thromb Haemost. Aug 2005;3(8):1763-72. [Medline].
DeBuys HV, Levy SB, Murray JC, Madey DL, Pinnell SR. Modern approaches to photoprotection. Dermatol Clin. Oct 2000;18(4):577-90. [Medline].
Feinstein RJ, Halprin KM, Penneys NS, Taylor JR, Schenkman J. Senile purpura. Arch Dermatol. Aug 1973;108(2):229-32. [Medline].
Goldstein DA, Schteingart MT, Birnbaum AD, Tessler HH. Bilateral eyelid ecchymoses and corneal crystals: an unusual presentation of multiple myeloma. Cornea. Aug 2005;24(6):757-8. [Medline].
Griffiths CE, Wang TS, Hamilton TA, Voorhees JJ, Ellis CN. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. Mar 1992;128(3):347-51. [Medline].
Jackson R. Elderly and sun-affected skin. Distinguishing between changes caused by aging and changes caused by habitual exposure to sun. Can Fam Physician. Jun 2001;47:1236-43. [Medline].
Joshi RS, Phadke VA, Khopkar US, Wadhwa SL. Unilateral solar purpura as a manifestation of asymmetrical photodamage in taxi drivers. Arch Dermatol. Jun 1996;132(6):715-6. [Medline].
Kalivas L, Kalivas J. Solar purpura. Arch Dermatol. Jan 1988;124(1):24-5. [Medline].
Kligman AM. Early destructive effect of sunlight on human skin. JAMA. Dec 29 1969;210(13):2377-80. [Medline].
Lawrence N. New and emerging treatments for photoaging. Dermatol Clin. Jan 2000;18(1):99-112. [Medline].
Ohnishi T, Nagayama T, Morita T, Miyazaki T, Okada H, Ohara K, et al. Angioma serpiginosum: a report of 2 cases identified using epiluminescence microscopy. Arch Dermatol. Nov 1999;135(11):1366-8. [Medline].
Ohnishi Y, Tajima S, Akiyama M, Ishibashi A, Kobayashi R, Horii I. Expression of elastin-related proteins and matrix metalloproteinases in actinic elastosis of sun-damaged skin. Arch Dermatol Res. Jan 2000;292(1):27-31. [Medline].
Rallis TM, Bakhtian S, Pershing LK, Krueger GG. Effects of 0.1% retinoic acid on Bateman's actinic purpura. Arch Dermatol. Apr 1995;131(4):493-5. [Medline].
Seo JY, Lee SH, Youn CS, Choi HR, Rhie GE, Cho KH, et al. Ultraviolet radiation increases tropoelastin mRNA expression in the epidermis of human skin in vivo. J Invest Dermatol. Jun 2001;116(6):915-9. [Medline].
Shuster S, Scarborough H. Senile purpura. Q J Med. Jan 1961;117:33-40.
Singer RS, Hamilton TA, Voorhees JJ, Griffiths CE. Association of asymmetrical facial photodamage with automobile driving. Arch Dermatol. Jan 1994;130(1):121-3. [Medline].
Sugimoto M, Takada T, Yasuda H, Nagashima I, Amano H, Yoshida M, et al. MPR-hCT imaging of the pancreatic fluid pathway to Grey-Turner's and Cullen's sign in acute pancreatitis. Hepatogastroenterology. Sep-Oct 2005;52(65):1613-6. [Medline].
Tattersall RN, Seville R. Senile purpura. Q J Med. Apr 1950;19:151-9.
Further Reading
Keywords
Bateman actinic purpura, solar purpura, senile purpura, ultraviolet radiation–induced skin changes, chronic sun exposure
Follow-up: Actinic Purpura